Lab test aims to match brain tumor patients with targeted drugs

This study is testing a new approach to personalize treatment for people with a fast-growing brain tumor called glioblastoma. Researchers will use a lab test on tumor cells to see which drugs might work best for each patient. The goal is to find out if this method can help more patients start maintenance therapy within 4-6 weeks after finishing a short course of radiation. About 30 adults with newly diagnosed glioblastoma will take part.